Showing results (1-10 of 63) with videos related to
Sort By:
Pageof 7
Journal of Acquired Immune Deficiency Syndromes (1999)|October 18, 2003
Tipranavir: a protease inhibitor from a new class with distinct antiviral activityPatrick YeniAntiviral Therapy|March 9, 2005
Nucleoside analogue-sparing strategy for the treatment of chronic HIV infection: potential interest and clinical experienceVronique Joly, Patrick YeniAnnales De Medecine Interne|March 24, 2004
[Progress in the management of pyogenic cerebral abscesses in non-immunocompromised patients]Jérôme Tourret, Patrick YeniExpert Review of Anti-Infective Therapy|June 23, 2011
Darunavir: an effective protease inhibitor for HIV-infected patientsBao-Chau Phung, Patrick YeniExpert Opinion on Emerging Drugs|April 26, 2006
Emerging reverse transcriptase inhibitors for the treatment of HIV infection in adultsClaude Fortin, Véronique Joly, Patrick YeniAIDS Reviews|November 6, 2002
NNRTI plus PI combinations in the perspective of nucleoside-sparing or nucleoside-failing antiretroviral regimensVéronique Joly, Diane Descamps, Patrick YeniLa Revue Du Praticien|December 17, 2014
[HIV infection and social condition: a disease which remains singular]Michel Celse, Laurent Geffroy, Patrick YeniExpert Opinion on Pharmacotherapy|October 28, 2010
Enfuvirtide: from basic investigations to current clinical useVéronique Joly, Kaoutar Jidar, Mercedes Tatay, et al.Virologie (Montrouge, France)|January 9, 2020
Antiretroviral treatments in 2012: improvements and future prospectsCharlotte Charpentier, Véronique Joly, Patrick Yeni, et al.Pageof 7